Literature DB >> 26886396

Platelet Function Tests in Bleeding Disorders.

Riitta Lassila1.   

Abstract

Functional disorders of platelets can involve any aspect of platelet physiology, with many different effects or outcomes. These include platelet numbers (thrombocytosis or thrombocytopenia); changes in platelet production or destruction, or capture to the liver (Ashwell receptor); altered adhesion to vascular injury sites and/or influence on hemostasis and wound healing; and altered activation or receptor functions, shape change, spreading and release reactions, procoagulant and antifibrinolytic activity. Procoagulant membrane alterations, and generation of thrombin and fibrin, also affect platelet aggregation. The above parameters can all be studied, but standardization and quality control of assay methods have been limited despite several efforts. Only after a comprehensive clinical bleeding assessment, including family history, information on drug use affecting platelets, and exclusion of coagulation factor, and tissue deficits, should platelet function testing be undertaken to confirm an abnormality. Current diagnostic tools include blood cell counts, platelet characteristics according to the cell counter parameters, peripheral blood smear, exclusion of pseudothrombocytopenia, whole blood aggregometry (WBA) or light transmission aggregometry (LTA) in platelet-rich plasma, luminescence, platelet function analysis (PFA-100) for platelet adhesion and deposition to collagen cartridges under blood flow, and finally transmission electron microscopy to exclude rare structural defects leading to functional deficits. The most validated test panels are included in WBA, LTA, and PFA. Because platelets are isolated from their natural environment, many simplifications occur, as circulating blood and interaction with vascular wall are omitted in these assays. The target to reach a highly specific platelet disorder diagnosis in routine clinical management can be exhaustive, unless needed for genetic counseling. The elective overall assessment of platelet function disorder primarily aims at better management of hemostasis in case of emergency surgery or other interventions and acute bleeding events. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26886396     DOI: 10.1055/s-0036-1571307

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  7 in total

Review 1.  Towards increasing shelf life and haemostatic potency of stored platelet concentrates.

Authors:  Shailaja Hegde; Huzoor Akbar; Yi Zheng; Jose A Cancelas
Journal:  Curr Opin Hematol       Date:  2018-11       Impact factor: 3.284

Review 2.  The effect of platelet storage temperature on haemostatic, immune, and endothelial function: potential for personalised medicine.

Authors:  Susan M Shea; Kimberly A Thomas; Philip C Spinella
Journal:  Blood Transfus       Date:  2019-07       Impact factor: 3.443

Review 3.  Diagnostic workup of inherited platelet disorders.

Authors:  Bohyun Kim
Journal:  Blood Res       Date:  2022-04-30

4.  A microengineered vascularized bleeding model that integrates the principal components of hemostasis.

Authors:  Yumiko Sakurai; Elaissa T Hardy; Byungwook Ahn; Reginald Tran; Meredith E Fay; Jordan C Ciciliano; Robert G Mannino; David R Myers; Yongzhi Qiu; Marcus A Carden; W Hunter Baldwin; Shannon L Meeks; Gary E Gilbert; Shawn M Jobe; Wilbur A Lam
Journal:  Nat Commun       Date:  2018-02-06       Impact factor: 14.919

5.  A simplified flow cytometric method for detection of inherited platelet disorders-A comparison to the gold standard light transmission aggregometry.

Authors:  Kristoffer Navred; Myriam Martin; Lina Ekdahl; Eva Zetterberg; Nadine Gretenkort Andersson; Karin Strandberg; Eva Norstrom
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

6.  Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.

Authors:  Sisse R Ostrowski; Ole S Søgaard; Martin Tolstrup; Nina B Stærke; Jens Lundgren; Lars Østergaard; Anne-Mette Hvas
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 7.561

7.  Antiplatelet and Antithrombotic Effects of Isaridin E Isolated from the Marine-Derived Fungus via Downregulating the PI3K/Akt Signaling Pathway.

Authors:  Ni Pan; Zi-Cheng Li; Zhi-Hong Li; Sen-Hua Chen; Ming-Hua Jiang; Han-Yan Yang; Yao-Sheng Liu; Rui Hu; Yu-Wei Zeng; Le-Hui Dai; Lan Liu; Guan-Lei Wang
Journal:  Mar Drugs       Date:  2021-12-24       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.